Remove 2009 Remove Form Remove Pharmaceutical
article thumbnail

Building an Integrated, End-to-End R&D and Manufacturing Service Platform with Innovative R&D and High-end Preparation Technologies

Frost & Sullivan Manufacturing

Aligning with Industry Trends: Healthnice Advances Step by Step Amid the global pharmaceutical industry’s evolution, high-end preparations have become a mainstream trend in drug development. Therefore, for pharmaceutical companies, high-end preparations represent a high-value, cost-effective strategy for differentiation.

article thumbnail

Top Legal Issues Facing the Manufacturing Sector in 2023

Foley

Consider the form of the relationship to mitigate potential risks. At the outset, companies can mitigate a significant amount of their potential risks and maximize opportunities by properly considering what form the relationship should take. Healthcare and Pharmaceuticals. These letters often are issued to major U.S.

article thumbnail

Transformational Growth Leadership: An Exclusive Interview with Yvonne Lungershausen, CEO, Avance Clinical

Frost & Sullivan Manufacturing

We have formed strategic partnerships to pilot AI-driven efficiencies. In 2009, Yvonne Lungershausen became a Founding Member of CPR Pharma Services (CPR) as it spun out from the University of South Australia. How has Avance Clinical leveraged AI to improve operations?